Hybrid
Collagen
Stimulators
Beautyeurope.eu is the sole distributor in Poland of LENISNA and JUVELOOK hybrid tissue stimulators based on poly D,L-lactic acid (PDLLA) and hyaluronic acid. These are certified class III implantable medical devices, manufactured by the Korean VAIM factory.
LENISNA – one of the most effective tissue stimulator in aesthetical medicine based on hybrid formula PDLLA + HA.
A hybrid collagen stimulator with a concentration of 170 mg of PDLLA and 30 mg of non-crosslinked hyaluronic acid.
More: www.lenisna.uk
JUVELOOK – the world's only hybrid Poly D,L-lactide acid + HA stimulator to be applied in the eye area and mesotherapy of face, neck and décolleté.
A hybrid collagen stimulator with a concentration of 42.5 mg of PDLLA and 7.5 mg of non-crosslinked hyaluronic acid.
More: www.juvelook.uk
Treatments using the products can be performed on the face, neck, cleavage, backs of hands and body.
During the AMWC congress in Monaco in 2025, Juvelook was honored with the prestigious AMWC Aesthetic Medicine Award in the category: Best injectable in skin revitalization.
Podczas kongresu AMWC w Monako 2025 preparat Juvelook został nagrodzony prestiżową nagrodą AMWC Aesthetic Medicine Award w kategorii: Best injectable in the skin revitalization.
Juvelook and Lenisna were also honored with the 2023 Aesthetic Dermatology Pearl – Safety Award in the following categories:
JUVELOOK – Injectable treatments – tissue stimulators – regeneration
LENISNA – Injectable treatments – tissue stimulators – volume restoration
Indications:
The preparation is intended for intradermal and subcutaneous implantation in order to restore and increase the volume of soft tissues. By adjusting the amount of the solution and the particle size from 10 to 40 micrometers and combining them with non-crosslinked hyaluronic acid, a hybrid was obtained suitable for mesotherapy application on:
- Face
- Neck and cleavage
Only cannula on:
- Eye area
A hybrid collagen stimulator with a concentration of 170 mg of PDLLA and 30 mg of non-crosslinked hyaluronic acid.
Indications:
By adjusting the amount of solution and particle size from 50 to 60 microns and combining them with non-crosslinked hyaluronic acid, a hybrid was obtained suitable for application in the subcutaneous tissue or periosteum. It is intended for the treatment of deep wrinkles, laxity, significant tissue defects in areas such as:
- Face
- Neck and cleavage
- Arms, buttock, stomach
